Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

When will there be a generic loreev available?
How to apply for vascepa's patient assistance?
Diltiazem drug class?
Novartis patent term dabrafenib?
When will latisse patent expire?

How long does a nexplanon implant last?

See the DrugPatentWatch profile for nexplanon

How Long Does Nexplanon Last?

Nexplanon, a small rod-shaped contraceptive implant inserted under the skin of the upper arm, provides birth control for up to 3 years.[1] It releases progestin (etonogestrel) steadily to prevent ovulation, thicken cervical mucus, and thin the uterine lining.

When Should You Replace It?

Remove or replace Nexplanon by the end of year 3 for continued effectiveness. Doctors can remove it earlier if needed, and fertility typically returns quickly afterward.[1]

Can It Last Longer Than 3 Years?

Studies support use up to 5 years in some cases, but the FDA approves it for only 3 years. Consult a healthcare provider before extending, as effectiveness may decline beyond the labeled duration.[1][2]

What Happens If You Leave It In Longer?

Risk of pregnancy increases after 3 years due to dropping hormone levels. No evidence of serious harm from leaving it in longer, but removal is recommended to avoid unintended pregnancy.[1]

Nexplanon vs. Other Implants

Nexplanon replaced Implanon (also 3 years) with a preloaded inserter for easier placement. It's more reliable long-term than pills (91% typical use) or IUDs like Mirena (up to 8 years).[1][3]

Who Makes Nexplanon and Any Patent Details?

Merck markets Nexplanon (U.S.) under Merck Sharp & Dohme. Core patents expired around 2018-2020, with some formulation patents lasting longer—check DrugPatentWatch.com for exact expiry dates and generics.[4]

[1]: FDA Nexplanon Label - https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021529s019lbl.pdf
[2]: CDC Contraceptive Guidance - https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/ingredients.html
[3]: Planned Parenthood Comparison - https://www.plannedparenthood.org/learn/birth-control/implant-nexplanon/how-effective-implant
[4]: DrugPatentWatch - https://www.drugpatentwatch.com/p/tradename/NEXPLANON



Other Questions About Nexplanon :

Nexplanon ndc? Can nexplanon expire early? How much nexplanon cost? Nexplanon oranfe book patents? Nexplanon expiration? When nexplanon expires? Ndc nexplanon?

AI-Drug Label Prescribing Information Alignment Report

100
100%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The AI response claim about complications from improper insertion/removal and the associated restricted REMS program is directly supported by the provided label sections (5.1, 5.2, 2.2, 2.3).

Category Scores

Warnings
100
Excellent
Warnings
100
Excellent

Accurate Statements

Risk of complications due to improper insertion and removal (and associated REMS program to mitigate that risk).
Supported by FDA label excerpts: Section 5.1 (complications from improper insertion/removal; neural/vascular injury if deeply inserted; migration; expulsion; difficulty/impossibility of removal; and failure to remove may lead to continued effects including compromised fertility/ectopic pregnancy) and Section 5.2 (NEXPLANON is only available through a restricted program under a REMS called NEXPLANON REMS due to risk of complications from improper insertion/removal, including provider certification/training and dispensing/distribution restrictions). Also aligned with insertion/removal technique requirements in Sections 2.2 (correct subdermal insertion; palpation verification immediately after insertion; training; do not attempt if unsure) and 2.3 (removal by trained healthcare professional; non-palpable implants handled by experienced professionals; exploratory surgery discouraged).

Unsupported Statements

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: Low
The evaluated claim is a safety/mitigation statement directly supported by the label and does not introduce unsupported medical guidance beyond label-reported risks and REMS requirements.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
78
Visibility
73
Mentioned
Ranking
#1
Sentiment
70
Recommendation Status
strong alternative
Brand Perception
Best Known For

provides birth control for up to 3 years

Core Claims
  • Provides birth control for up to 3 years
  • Releases progestin (etonogestrel) steadily to prevent ovulation
  • Remove or replace by the end of year 3 for continued effectiveness
  • Studies support use up to 5 years in some cases, but FDA approves it for only 3 years
  • Risk of pregnancy increases after 3 years due to dropping hormone levels
Differentiators
  • Releases progestin (etonogestrel) steadily to prevent ovulation
  • Replaced Implanon with a preloaded inserter for easier placement
  • Described as more reliable long-term than pills or IUDs like Mirena
Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Merck 10%
50 #7 No
FDA 10%
50 #9 No
CDC 10%
50 #10 No
Mirena 53%
55 #6 No
Implanon 46%
50 #5 No